NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has entered into a collaboration with the J. Craig Venter Institute, under which JVCI has purchased one of the firm’s Barocycler NEP2320 PCT Sample Preparation Systems.
 
JVCI will use the system, which incorporates the firm’s pressure cycling technology, for its research as part of the NIH-funded Human Microbiome Project. Pressure Bio also intends to provide JCVI with two more instruments for additional studies as part of the collaboration.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.